New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 24, 2014
04:55 EDTCRME, CRME, ALR, ALR, GALE, GALE, BIND, BIND, AVNR, AVNR, OCRX, OCRX, ONVO, ONVO, OSIR, OSIR, SGNT, SGNT, SNTA, SNTA, CRIS, CRISJMP Securities to hold a conference
Healthcare Conference to be held in New York on June 24-25.
News For CRME;SNTA;SGNT;OSIR;ONVO;OCRX;AVNR;BIND;GALE;ALR;CRIS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 5, 2015
07:20 EDTSGNTSagent Pharmaceuticals sees FY15 revenue $325M-$375M, consensus $345.76M
07:19 EDTSGNTSagent Pharmaceuticals reports Q1 EPS with-items (6c), consensus 4c
Subscribe for More Information
07:13 EDTALRAlere sees FY15 non-GAAP EPS $2.40-$2.50, consensus $2.43
Sees FY15 revenue $2.5B-$2.6B, consensus $2.58B.
07:13 EDTALRAlere says restatement not expected to impact 2015 financial guidance
Alere commented, "The error in the accounting for income taxes associated with the Alere Health divestiture was primarily due to the incorrect determination of the book basis of the businesses sold. We expect that the adjustments related to these dispositions and other individually immaterial adjustments that will be recorded will decrease our GAAP income from discontinued operations, net of tax, in 2014, by between $36M and $50M, and will increase our GAAP loss from continuing operations in 2014 by between $9M and $13M. On a non-GAAP adjusted basis, we expect that the adjustments will decrease our income from continuing operations in 2014 by between $6M and $8M.
07:12 EDTALRAlere reports preliminary Q1 non-GAAP EPS 57c, consensus 49c
Reports preliminary Q1 adjusted revenue $610.7M, consensus $612.93M. Reports preliminary Q1 organic growth of 2.6%. Reports preliminary Q1 organic growth, excluding North America influenza sales, of 0.5%.
May 4, 2015
12:14 EDTOCRXOcera Therapeutics management to meet with JMP Securities
Meetings to be held in New York on May 4-5 hosted by JMP Securities.
08:12 EDTOCRXOcera Therapeutics Chief Development Officer Rajiv Patni, M.D. steps down
Ocera Therapeutics announced that Rajiv Patni, M.D., Chief Development Officer, has decided to step down from his position for personal reasons, effective June 1. The company's former Chief Development and Chief Medical Officer, Franck Rousseau, M.D., who has been a consultant with Ocera since his departure, will lead the company's clinical development efforts on an interim basis.
07:21 EDTCRMEBloom Burton & Co to hold a conference
Subscribe for More Information
April 30, 2015
08:17 EDTOCRXOcera Therapeutics backs FY15 net use of cash guidance of $28M-$32M
Subscribe for More Information
08:17 EDTOCRXOcera Therapeutics reports Q1 EPS (34c), consensus (36c)
Subscribe for More Information
April 27, 2015
07:36 EDTSNTASynta Pharmaceuticals names Chen Schor CEO
Synta Pharmaceuticals announced that Chen Schor, executive vice president, COO, has been named president, CEO and a director of the company, effective May 7. Schor replaces Anne Whitaker, who is stepping down from her roles at Synta to pursue a professional opportunity at a large multinational pharmaceutical company. Schor joined Synta as executive vice president and COO in December 2014.
April 22, 2015
16:44 EDTONVOOn The Fly: Top stock stories for Wednesday
Stocks on Wall Street began the session in positive territory, but turned negative shortly after the open. The downside move failed to gain momentum and the averages remained near the flat line for most of the morning. The market moved to session highs by mid-afternoon and drifted higher into the close, as investors prepared for another round of earnings reports. ECONOMIC EVENTS: In the U.S., existing home sales rose 6.1% to a 5.19M rate in March, which was better than the expected 3.1% increase to a rate of 5.03M. Crude oil inventories built up by 5.32M barrels last week, which was more than the consensus forecast for a 3.2M barrel build. In Asia, Japan's Nikkei 225 average closed above 20,000 for the first time since April 2000. In Europe, Germany raised its economic growth forecast for 2015 to 1.8%, which was up from the 1.5% growth it said it expected in January. COMPANY NEWS: Shares of Visa (V) rose $2.66, or 4.07%, to $68.01 and MasterCard (MA) advanced $3.43, or 3.91%, to $91.20 after China's State Council announced overnight that the country will regulate the market access for bankcard transaction clearing institutions, which analysts think might allow both companies to compete for the processing of domestic transactions in the country. Goldman Sachs said the overall rule is broader and simpler than expected, raising the possibility that Visa and MasterCard could operate more freely in China than the firm had previously expected... Shares of McDonald's (MCD) advanced $2.97, or 3.13%, to $97.84 after the company reported headline earnings that missed expectations but also said it is developing a turnaround plan to improve its performance and deliver "enduring profitable growth" that it plans to share in the first week of May. MAJOR MOVERS: Among the notable gainers was Organovo (ONVO), which surged 67c, or 14.99%, to $5.14 after disclosing the company entered into a multi-year research collaboration agreement with Merck (MRK) that gives the drugmaker access to Organovo’s commercial exVive3D Human Liver Tissue service. Also higher was Vitamin Shoppe (VSI), which gained $5.54, or 14.22%, to $44.50 after asset management firm Carlson Capital revealed that it had obtained a 5.34% stake in the company and said that it had held talks with the retailer of natural treatments, supplements and vitamins. Among the noteworthy losers was Natural Resource Partners (NRP), which dropped $1.38, or 19.94%, to $5.54 after the company slashed its quarterly distribution by 75% to 9c per unit. Also lower were shares of Chipotle Mexican Grill (CMG), which fell $51.29, or 7.41%, to $641.23 after the company reported lower than expected first quarter comparable sales growth of 10.4%. INDEXES: The Dow rose 88.68, or 0.49%, to 18,038.27, the Nasdaq gained 21.07, or 0.42%, to 5,035.17, and the S&P 500 advanced 10.67, or 0.51%, to 2,107.96.
09:22 EDTONVOOn The Fly: Pre-market Movers
UP AFTER EARNINGS: CalAmp (CAMP), up 12.7%... Angie's List (ANGI), up 17.4%... Broadcom (BRCM), up 6.3%... Owens Corning (OC), up 3.8%... Yum! Brands (YUM), up 3.3%... Dolby Laboratories (DLB), up 3.6%... Infinera (INFN), up 2.4%... AutoNation (AN), up 2.5%... Amgen (AMGN), up 3.1%... Coca-Cola (KO), up 2%. ALSO HIGHER: Procera Networks (PKT) up 10.4% after being acquired by Francisco Partners in deal valued at $240M... Organovo (ONVO), up 19.2% after entering into a collaboration agreement with Merck Sharp and Dohme... Vical (VICL), up 5.8% after being awarded $4M contract to manufacture HIV vaccines for clinical evaluation... CTI BioPharma (CTIC), up 4.9% after announcing that Phase 3 pacritinib data will be highlighted in a late-breaking oral presentation at ASCO meeting. DOWN AFTER EARNINGS: Chipotle Mexican Grill (CMG), down 5.2%... iRobot (IRBT), down 3.6%... Cree (CREE), down 3.5%... United Rentals (URI), down 4%... Super Micro Computer (SMC), down 2.3%... Thermo Fisher (TMO), down 2.6%. ALSO LOWER: Natural Resource Partners (NRP), down 14% after reducing quarterly distribution 75% to 9c per unit... Trinity Industries (TRN), down 3.5% following a Bloomberg report that the Justice Department has initiated a criminal investigation into Trinity guardrails.
08:18 EDTONVOOrganovo enters into a collaboration agreement with Merck Sharp and Dohme
Subscribe for More Information
08:04 EDTBINDBIND Therapeutics presents data on BIND-014, AZD2811 at AACR
Subscribe for More Information
07:01 EDTSNTAAveo Oncology names Keith Ehrlich as CFO
Subscribe for More Information
April 21, 2015
17:08 EDTONVOOrganovo sees Q4 revenue $268,000, consensus $300,000.
Subscribe for More Information
10:01 EDTSNTAOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Agios Pharmaceuticals (AGIO) initiated with a Perform at Oppenheimer... Bed Bath & Beyond (BBBY) initiated with a Buy at Cantor... BioCryst (BCRX) initiated with an Outperform at FBR... Bovie Medical (BVX) initiated with an Outperform at JMP Securities... Calavo Growers (CVGW) initiated with a Buy at Janney Capital... Clorox (CLX) initiated with a Sector Weight at KeyBanc... Coach (COH) initiated with a Sell, $32 target at Cantor... Compugen (CGEN) initiated with an Outperform at Oppenheimer... Corcept Therapeutics (CORT) initiated with an Outperform at FBR Capital... Criteo (CRTO) initiated with an Outperform at Raymond James... CytRx (CYTR) initiated with an Outperform at FBR Capital... Dollar Tree (DLTR) initiated with a Buy at Cantor... Facebook (FB) initiated with a Buy at Cleveland Research... Gap (GPS) initiated with a Hold at Cantor... Genocea (GNCA) initiated with an Outperform at FBR Capital... Geron (GERN) initiated with an Outperform at Oppenheimer... Home Depot (HD) initiated with a Hold at Cantor... HubSpot (HUBS) initiated with a Buy at Needham... Jernigan Capital (JCAP) initiated with a Buy at Wunderlich... La Jolla (LJPC) initiated with an Outperform, $43 target at Oppenheimer... Lowe's (LOW) initiated with a Hold at Cantor... Lumber Liquidators (LL) initiated with a Buy, $45 target at Cantor... New Residential (NRZ) reinstated with an Outperform at Credit Suisse... Rent-A-Center (RCII) initiated with a Buy at Cantor... Ross Stores (ROST) initiated with a Hold at Cantor... Rubicon Project (RUBI) initiated with an Outperform at Raymond James... SolarCity (SCTY) initiated with an Outperform at Northland... SolarEdge (SEDG) initiated with a Buy at Canaccord... Spectrum Brands (SPB) initiated with an Overweight at KeyBanc... Summit Materials (SUM) initiated with a Buy at BB&T... Synergy Resources (SYRG) initiated with a Buy at KLR Group... Synta Pharmaceuticals (SNTA) initiated with an Outperform at FBR Capital... TJX (TJX) initiated with a Hold at Cantor... Tiffany (TIF) initiated with a Hold at Cantor... TubeMogul (TUBE) initiated with a Market Perform at Raymond James... Urban Outfitters (URBN) initiated with a Buy at Cantor... WhiteWave Foods (WWAV) initiated with a Neutral at Janney Capital... Williams-Sonoma (WSM) initiated with a Hold at Cantor... Zafgen (ZFGN) initiated with an Outperform at FBR Capital.
09:34 EDTGALEGalena sent FDA warning letter following site inspection
A warning letter published by the FDA, dated April 3, states that the agency's inspection of Galena Biopharma's site in Portland, Oregon, conducted between November 17 and 21, 2014, revealed "serious violations" of FDA’s PADE reporting requirements. Reference Link
05:50 EDTSNTASynta Pharmaceuticals initiated with an Outperform at FBR Capital
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use